Lipid accumulation and interstitial lung disease associated with amikacin liposomal inhalation suspension in patients with Mycobacterium avium complex lung disease: a single-center retrospective cohort study

Abstract Background Amikacin liposomal inhalation suspension (ALIS), an inhaled aminoglycoside, can effectively treat refractory or relapsed Mycobacterium avium complex lung disease (MAC-LD). However, ALIS is associated with interstitial lung disease (ILD), and underlying pathological mechanisms are...

Descripció completa

Dades bibliogràfiques

Autors principals:	Hiroki Wakabayashi, Kazutoshi Isobe, Nobuyuki Hiruta, Shusuke Kasuya, Atsushi Sano, Yasuo Matsuzawa
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2026-03-01
Col·lecció:	BMC Pulmonary Medicine
Matèries:	Amikacin Bronchoalveolar lavage Drug-induced interstitial lung disease Exogenous lipoid Lipoid pneumonia Mycobacterium avium complex
Accés en línia:	https://doi.org/10.1186/s12890-026-04213-2
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!